|
A more recent version of this article appeared on September 1, 2005
Papers In Press, published online ahead of print July 1, 2005
J. Lipid Res., doi:10.1194/jlr.M500074-JLR200
Submitted on February 23, 2005
Revised on May 31, 2005
Accepted on June 20, 2005
Molecular and mechanistic characterization of platelet-activating-factor-like bioactivity produced upon Cooper-catalyzed LDL oxidation
Nicolaos Androulakis, Herve Durand, Ewa Ninio, and Demokritos C Tsoukatos
Department of Chemistry, University of Ioannina, Ioannina, Ioannina 45110
Corresponding Author: dtsoykat{at}cc.uoi.gr
Oxidation of LDL is thought to be involved in both initiating and sustaining atherogenesis through the formation of pro-inflammatory lipids and the covalent modification of LDL particles. Platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is a potent phospholipid mediator involved in inflammation. Upon oxidation of LDL, a large amount of oxidized phospholipids with PAF-like structure, is generated by fragmentation of the polyunsaturated fatty acyl moieties esterified at sn-2 position of glycerol. Some of the oxidatively generated PAF analogs may act via the PAF receptor. We evaluated the contribution of 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine (C16:0 PAF) as well as of other PAF analogs, on the PAF-like bioactivity formed upon Cu2+-initiated oxidation of LDL. RP-HPLC purification, and ESI-MS analyses showed that upon oxidation of LDL, with inactivated PAF-acetylhydrolase, C16:0 PAF accounted for more than 30% of PAF-like biological activity and its sn-2 boutenoyl analogue for more than 50%. However upon LDL oxidation in the presence of exogenous lyso-PAF without PAF-acetylhydrolase inactivation, C16:0 PAF formation accounted for more than 90% of the biological activity recovered. We suggest, that the C16:0 PAF, despite being a minor constituent of the LDL peroxidation products, may substantially contribute to the bioactivity formed in oxidized LDL. The higher bioactivity of C16:0 PAF, and the higher selectivity of the LDL attached lyso-PAF transacetylase towards very short acyl chains (acetate (C2) vs boutanate (C4)), may explain the above contribution.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Chen, X. Chen, R. G. Salomon, and T. M. McIntyre
Platelet Activation by Low Concentrations of Intact Oxidized LDL Particles Involves the PAF Receptor
Arterioscler Thromb Vasc Biol,
March 1, 2009;
29(3):
363 - 371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Tsoukatos, I. Brocheriou, V. Moussis, C. P. Panopoulou, E. D. Christofidou, S. Koussissis, S. Sismanidis, E. Ninio, and S. Siminelakis
Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary artery
J. Lipid Res.,
October 1, 2008;
49(10):
2240 - 2249.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|